Strategic Partnership
Novavax and Catalent Biologics Enter Strategic Partnershipto Expand Gene Therapy Footprint
Catalent Biologics
PR-M07-19-NI-001Jul 01, 2019
M&A
Catalent Completes Acquisition Of Gene Therapy Leader Paragon Bioservices, Inc. For $1.2 Billion
Catalent
PR-M05-19-NI-071May 24, 2019